The sugar rush is a myth. A gold SR+MA of acute carbohydrate (CHO) challenge trials in healthy adults finds no mood-boosting effect at any time-point — and the only signals that reach significance run the other way: within the first hour CHO leaves people less alert and more fatigued than placebo. This refutes the widely-held belief that sugar or a sugary drink gives a quick lift in mood or energy. (Mantantzis et al., 2019)
This is an acute mood/alertness question (minutes-to-hours after ingestion, healthy adults). It is a different decision from chronic depression (-> Depression and Modifiable Exposures, a scope/horizon distinction, not a tension) and from how-much-sugar-to-eat (-> Free Sugars Intake, the cost side).
The finding
The meta-analysis pooled 176 effect sizes from 31 RCTs (1259 participants), comparing carbohydrate against placebo on subjective mood across three time windows (0-30, 31-60, 61+ minutes) (Mantantzis et al., 2019).
- No mood benefit, anywhere. No positive effect of CHO on any mood construct (alertness, calmness, contentedness, vigor, or the reverse-scored negatives) at any time-point. The pooled effects were homogeneous across constructs and windows (I2 = 0% in most cells; the exceptions are a few 61+ min constructs) — a consistent null, not a washed-out average of clashing studies. (Mantantzis et al., 2019)
- The serotonin prediction failed. The mechanistic case for a mood lift (CHO -> tryptophan -> brain serotonin) predicts an effect beyond the first hour; the 61+ min window is exactly where no facilitation appeared. The outcome-level null is the check the peripheral-biomarker mechanism did not pass. (Mantantzis et al., 2019)
- The only significant effects are decrements (a mild HARM direction):
- Fatigue rises, 0-30 min: CHO -> significantly higher fatigue than placebo (9 studies, p=.011). The same direction held (non-significantly) at 31-60 min. (Mantantzis et al., 2019)
- Alertness falls, 31-60 min: alertness was lower on CHO than placebo in all three windows, significant in the second (12 studies, p=.020). (Mantantzis et al., 2019)
- The one whiff of benefit is the least trustworthy number. Overall-mood at 61+ min showed a marginal positive trend (p=.051) — but it was flagged for publication bias (Begg/Egger p=.058/.089) and built partly from selectively reported subscales, so the authors explicitly discount it. (Mantantzis et al., 2019)
The narrow carve-out — physical exertion
The single context where CHO reduced fatigue was during/after physically demanding tasks (the only moderator that approached significance for fatigue at 61+ min: b=0.474, 95% CI [0.04, 0.91], p=.037) — NOT after cognitive tasks or at rest (Mantantzis et al., 2019). This is the sports-nutrition case (fuelling strenuous exercise), not a general everyday mood/energy boost. CHO dose (>/< 25 g), CHO type, and fasting interval did not move mood — so which sugar, how much, fasted or not is not the lever people imagine it is.
Decision relevance
- The claimed benefit is a phantom. Reaching for a sugary snack or drink for energy or to pick myself up does not deliver, in the healthy-adult stratum, on the acute timescale people expect it to — and within the first hour it slightly worsens alertness and fatigue. Anyone using this heuristic can drop it. This is a confirmed refutation of a common belief, as reportable as a confirmation.
- It removes an offset against the free-sugar cost. The acute lift was the main benefit people put on sugar’s side of the ledger; the MA empties it. With no acute upside, the free-sugars cardiometabolic and dental costs (-> Free Sugars Intake, whose beverage limb carries the SSB dose-response) stand unopposed for this use-case, and a lower-sugar substitute loses nothing on mood/energy.
- The substitute is water or nothing for the mood/energy motive; keep sugar for the palatability or the exertion-fuelling motive, judged on its own terms.
Limits + scope
- Surrogate, acute outcome. Mood is self-reported on scales (Bond-Lader VAS, POMS) measured within hours — a surrogate, not a patient-important physical endpoint, and silent on chronic mood. Mental wellbeing is peripheral to the physical-health telos; this page earns its place by killing a belief that drives consumption, not by mood as an end in itself.
- Healthy adults only. Clinical/subclinical populations (diagnosed depression, high stress-sensitivity, obesity, luteal phase) were out of scope; the authors note their mood «could be more sensitive to CHO manipulations» (Mantantzis et al., 2019). So this does NOT speak to carbohydrate-craving self-medication in depression — that is Depression and Modifiable Exposures’ chronic question, a different scope and horizon.
- Carbohydrate in isolation. CHO+caffeine energy-drink synergies and CHO+protein combinations were largely excluded — the null is about sugar/CHO alone.
- Single-source page. One gold MA; the refute-of-benefit direction is well-supported (31 RCTs, low heterogeneity, consistent, mechanism-prediction failed), the harm-direction (worse alertness/fatigue) is weaker (significant in only some windows). No second SR/MA is held on the acute question.